Trial intelligence / Profile preview

PG-760564 in Adult Patients With RA Receiving Methotrexate

NCT00369928Phase 2Completed

Sponsor
Procter & Gamble
Start
Aug 2006
Primary completion
Jan 2008
Modality
Small Molecules
Countries
6
01

Overview

A Phase 2 trial of PG-760564 in rheumatoid arthritis (RA), sponsored by Procter & Gamble. Started Aug 2006; status: completed.

02

Drugs

PG-760564
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT00369928.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00369928.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call